Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 33973 | 118 | 33.3 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 230 | 3 | P GLYCOPROTEIN//FMO3//TRIMETHYLAMINURIA | 49374 |
| 747 | 2 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//MDR1 | 12474 |
| 33973 | 1 | MDR I//RHEUMATOLOTA KU//BIOLOGIC AGENT THERAPY | 118 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | MDR I | authKW | 517552 | 2% | 100% | 2 |
| 2 | RHEUMATOLOTA KU | address | 345030 | 3% | 33% | 4 |
| 3 | BIOLOGIC AGENT THERAPY | authKW | 258776 | 1% | 100% | 1 |
| 4 | BITTERN WATER | authKW | 258776 | 1% | 100% | 1 |
| 5 | BLOOD CONCENTRATION MEASUREMENT | authKW | 258776 | 1% | 100% | 1 |
| 6 | DRUG TOXICITY ARTHRITIS | authKW | 258776 | 1% | 100% | 1 |
| 7 | FIBROBLAST LIKE SYONOVIOCYTES | authKW | 258776 | 1% | 100% | 1 |
| 8 | HOSPITAL BASED PROSPECTIVE OBSERVATIONAL COHORT | authKW | 258776 | 1% | 100% | 1 |
| 9 | HUMAN MULTIDRUG RESISTANCE 1 GENE | authKW | 258776 | 1% | 100% | 1 |
| 10 | INMMUNOL REUMATOL | address | 258776 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Rheumatology | 8700 | 49% | 0% | 58 |
| 2 | Immunology | 98 | 15% | 0% | 18 |
| 3 | Pharmacology & Pharmacy | 51 | 14% | 0% | 17 |
| 4 | Medicine, Research & Experimental | 19 | 6% | 0% | 7 |
| 5 | Hematology | 8 | 3% | 0% | 4 |
| 6 | Primary Health Care | 7 | 1% | 0% | 1 |
| 7 | Cell Biology | 6 | 6% | 0% | 7 |
| 8 | Pediatrics | 5 | 3% | 0% | 4 |
| 9 | Allergy | 2 | 1% | 0% | 1 |
| 10 | Multidisciplinary Sciences | 1 | 1% | 0% | 1 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | RHEUMATOLOTA KU | 345030 | 3% | 33% | 4 |
| 2 | INMMUNOL REUMATOL | 258776 | 1% | 100% | 1 |
| 3 | NAGOYA UNIV HOSPSHOWA KU | 258776 | 1% | 100% | 1 |
| 4 | OTA KU INTERNAL MED | 258776 | 1% | 100% | 1 |
| 5 | RHEUMATOL INTERNAL MED CLIN MED | 258776 | 1% | 100% | 1 |
| 6 | MED BIOL S | 161292 | 10% | 5% | 12 |
| 7 | DANINI HOSP | 129387 | 1% | 50% | 1 |
| 8 | MED INFORMAT NETWORK | 129387 | 1% | 50% | 1 |
| 9 | RHEUMATOL AGEN DIS | 129387 | 1% | 50% | 1 |
| 10 | RHEUMATOLSHINJYUKU KU | 129387 | 1% | 50% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | MODERN RHEUMATOLOGY | 39566 | 12% | 1% | 14 |
| 2 | RHEUMATOLOGY INTERNATIONAL | 2806 | 6% | 0% | 7 |
| 3 | CLINICAL RHEUMATOLOGY | 2375 | 6% | 0% | 7 |
| 4 | INFLAMMATION RESEARCH | 2309 | 4% | 0% | 5 |
| 5 | JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY | 1436 | 1% | 1% | 1 |
| 6 | INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES | 1333 | 2% | 0% | 2 |
| 7 | ARTHRITIS AND RHEUMATISM | 1230 | 6% | 0% | 7 |
| 8 | INTERNATIONAL IMMUNOPHARMACOLOGY | 953 | 3% | 0% | 4 |
| 9 | JOURNAL OF RHEUMATOLOGY | 725 | 5% | 0% | 6 |
| 10 | ANNALS OF THE RHEUMATIC DISEASES | 722 | 4% | 0% | 5 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | TAKAKUBO, Y , TAMAKI, Y , HIRAYAMA, T , IWAZAKI, K , YANG, S , SASAKI, A , NAKANO, H , KONTTINEN, YT , TAKAGI, M , (2012) MIDTERM CLINICO-RADIOLOGIC FINDINGS OF AN OPEN LABEL OBSERVATION STUDY OF ADD-ON TACROLIMUS WITH BIOLOGICS OR NON-BIOLOGIC DMARDS.RHEUMATOLOGY INTERNATIONAL. VOL. 32. ISSUE 11. P. 3487 -3494 | 21 | 64% | 2 |
| 2 | OGASAWARA, M , TAMURA, N , KAGEYAMA, M , ONUMA, S , KUSAOI, M , TOYAMA, S , SEKIYA, F , MATSUDAIRA, R , NAWATA, M , TADA, K , ET AL (2012) SINGLE-CENTER, RETROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY OF TACROLIMUS AS A SECOND-LINE DMARD IN COMBINATION THERAPY AND THE RISK FACTORS CONTRIBUTING TO ADVERSE EVENTS IN 115 PATIENTS WITH RHEUMATOID ARTHRITIS.CLINICAL RHEUMATOLOGY. VOL. 31. ISSUE 2. P. 251-257 | 10 | 83% | 4 |
| 3 | SUZUKI, K , KAMEDA, H , AMANO, K , NAGASAWA, H , TAKEI, H , SEKIGUCHI, N , NISHI, E , OGAWA, H , TSUZAKA, K , TAKEUCHI, T , (2009) SINGLE CENTER PROSPECTIVE STUDY OF TACROLIMUS EFFICACY AND SAFETY IN TREATMENT OF RHEUMATOID ARTHRITIS.RHEUMATOLOGY INTERNATIONAL. VOL. 29. ISSUE 4. P. 431 -436 | 11 | 79% | 10 |
| 4 | GARCIA-CARRASCO, M , MENDOZA-PINTO, C , DIAZ, SM , VERA-RECABARREN, M , DE LARA, LV , MARTINEZ, SM , SOTO-SANTILLAN, P , GONZALEZ-RAMIREZ, R , RUIZ-ARGUELLES, A , (2015) P-GLYCOPROTEIN IN AUTOIMMUNE RHEUMATIC DISEASES.AUTOIMMUNITY REVIEWS. VOL. 14. ISSUE 7. P. 594 -600 | 15 | 37% | 6 |
| 5 | KANESHIRO, S , EBINA, K , HIRAO, M , TSUBOI, H , NISHIKAWA, M , NAMPEI, A , NAGAYAMA, Y , TAKAHI, K , NOGUCHI, T , OWAKI, H , ET AL (2017) THE EFFICACY AND SAFETY OF ADDITIONAL ADMINISTRATION OF TACROLIMUS IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO SHOWED AN INADEQUATE RESPONSE TO TOCILIZUMAB.MODERN RHEUMATOLOGY. VOL. 27. ISSUE 1. P. 42 -49 | 13 | 42% | 0 |
| 6 | CURRAN, MP , PERRY, CM , (2005) TACROLIMUS - IN PATIENTS WITH RHEUMATOID ARTHRITIS.DRUGS. VOL. 65. ISSUE 7. P. 993-1001 | 14 | 48% | 7 |
| 7 | MORITA, Y , SASAE, Y , SAKUTA, T , SATOH, M , SASAKI, T , KASHIHARA, N , (2008) EFFICACY OF LOW-DOSE TACROLIMUS ADDED TO METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS IN JAPAN: A RETROSPECTIVE STUDY.MODERN RHEUMATOLOGY. VOL. 18. ISSUE 4. P. 379 -384 | 8 | 73% | 11 |
| 8 | PRASAD, S , TRIPATHI, D , RAI, MK , AGGARWAL, S , MITTAL, B , AGARWAL, V , (2014) MULTIDRUG RESISTANCE PROTEIN-1 EXPRESSION, FUNCTION AND POLYMORPHISMS IN PATIENTS WITH RHEUMATOID ARTHRITIS NOT RESPONDING TO METHOTREXATE.INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES. VOL. 17. ISSUE 8. P. 878 -886 | 12 | 41% | 1 |
| 9 | KANZAKI, T , KAWAHATA, K , KANDA, H , FUJIO, K , KUBO, K , AKAHIRA, L , MICHISHITA, K , ERI, T , YAMAMOTO, K , (2013) LONG-TERM THERAPEUTIC EFFECTS AND SAFETY OF TACROLIMUS ADDED TO METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS.RHEUMATOLOGY INTERNATIONAL. VOL. 33. ISSUE 4. P. 871 -877 | 10 | 50% | 2 |
| 10 | AGARWAL, V , MITTAL, SK , MISRA, R , (2009) EXPRESSION OF MULTIDRUG RESISTANCE-1 PROTEIN CORRELATES WITH DISEASE ACTIVITY RATHER THAN THE REFRACTORINESS TO METHOTREXATE THERAPY IN RHEUMATOID ARTHRITIS.CLINICAL RHEUMATOLOGY. VOL. 28. ISSUE 4. P. 427 -433 | 10 | 50% | 11 |
Classes with closest relation at Level 1 |